Solitary fibrous tumor of kidney and renal hilus: a multi-institutional clinicopathologic analysis of 43 cases

. 2025 Sep 18 ; () : . [epub] 20250918

Status Publisher Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid40965627
Odkazy

PubMed 40965627
DOI 10.1007/s00428-025-04264-6
PII: 10.1007/s00428-025-04264-6
Knihovny.cz E-zdroje

Solitary fibrous tumor (SFT) is a fibroblastic neoplasm characterized by prominent, staghorn, or delicate "hemangiopericytoma (HPC)-like vasculature", NAB2::STAT6 gene fusion, and its surrogate STAT6 expression. SFT may exhibit an unpredictable clinical course, necessitating risk assessment based on tumor characteristics. Renal SFTs are rare and have not been well characterized. Forty-three primary kidney SFT cases are reviewed for clinical, morphological, and immunohistochemical (STAT6, BCL2, CD34, and PAX8) features. A four-variable risk stratification by Demicco was applied based on patient age, tumor size, mitotic activity, and tumor necrosis. The mean age was 49 years (range 11-83 years) with a slight female predominance (male:female = 20:23). The mean tumor size was 7.8 cm (1.6-32 cm). Tumors were mainly located at the hilus (22/32, 68%) and had well-demarcated borders (31/42, 74%). Morphologically, tumors were categorized as 1) Fibrous ("SFT-like", 19/43, 44%), characterized by hypocellularity and prominent fine-reticular or keloidal collagen; 2) Cellular ("HPC-like", 8/43, 19%), with hypercellularity, short spindle to small cell-like proliferation, and lacking a collagenous background; 3) mixed fibrous/cellular (16/43, 37%) displaying both components. Four cases featured a lipomatous component. BCL2 was positive in all tested cases (28/28), CD34 in all but 3 cases (93%), and STAT6 in all but one case (39/40, 97.5%). PAX8 was positive in 6/34 (18%) cases. Most cases (29/43, 68%) were classified as low-risk, followed by intermediate (12/43, 27%) and high-risk (2/43, 5%) groups. Five of 29 (18%) patients had metastatic disease, and two patients with high-risk and one with intermediate-risk tumors died from the disease, while 25 patients with low- or intermediate-risk tumors were alive for an average of about 36 months. We emphasize the usefulness of the risk stratification system in predicting prognosis. PAX8 expression in a subset of renal SFT represents a potential diagnostic pitfall.

Zobrazit více v PubMed

Chmielecki J, Crago AM, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, Auclair D, McKenna A, Heinrich MC, Frank DA, Meyerson M (2013) Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45:131–132. https://doi.org/10.1038/ng.2522 PubMed DOI PMC

Soft tissue and bone tumours (2020) WHO classification of tumours, vol 3, 5th edn. International Agency for Research on Cancer, Lyon

Soft tissue and bone tumours (2013) WHO classification of tumours, vol 2, 4th edn. International Agency for Research on Cancer, Lyon

Khater N, Khauli R, Shahait M, Degheili J, Khalifeh I, Aoun J (2013) Solitary fibrous tumors of the kidneys: presentation, evaluation, and treatment. Urol Int 91:373–383. https://doi.org/10.1159/000354394 PubMed DOI

Kuroda N, Ohe C, Sakaida N, Uemura Y, Inoue K, Nagashima Y, Hes O, Michal M (2014) Solitary fibrous tumor of the kidney with focus on clinical and pathobiological aspects. Int J Clin Exp Pathol 7:2737–2742 PubMed PMC

Wang H, Liao Q, Liao X, Wen G, Li Z, Lin C, Zhao L (2014) A huge malignant solitary fibrous tumor of kidney: case report and review of the literature. Diagn Pathol 9:13. https://doi.org/10.1186/1746-1596-9-13 PubMed DOI PMC

Chen Y, Wang F, Han A (2015) Fat-forming solitary fibrous tumor of the kidney: a case report and literature review. Int J Clin Exp Pathol 8:8632–8635 PubMed PMC

Abeygunasekera AM, Ginige AP, Liyanage IS, Hareendra K (2015) A solitary fibrous tumor of the kidney. J Cancer Res Ther 11:662. https://doi.org/10.4103/0973-1482.138128 PubMed DOI

Cheung F, Talanki VR, Liu J, Davis JE, Waltzer WC, Corcoran AT (2016) Metachronous malignant solitary fibrous tumor of kidney: case report and review of literature. Urol Case Rep 4:45–47. https://doi.org/10.1016/j.eucr.2015.09.004 PubMed DOI

Nakajima R, Abe K, Kondo T, Nagashima Y, Kimura K, Fukushima K, Momose M, Kondo C, Tanabe K, Sakai S (2015) FDG-PET/CT and CT findings of a benign solitary fibrous tumor of the kidney; correlation with pathology. Asia Ocean J Nucl Med Biol 3:116–119 PubMed PMC

Chen X, Wang JF, Ding ZS, Zhou XF (2018) Solitary fibrous tumor of the kidney treated with laparoscopic partial nephrectomy: a case report. Chin Med Sci J 33:64–68. https://doi.org/10.24920/31803 PubMed DOI

Lalwani AK, Faiq SM, Ahuja J (2018) Solitary fibrous tumor of kidney. J Coll Physicians Surg Pak 28:564–565. https://doi.org/10.29271/jcpsp.2018.07.564 PubMed DOI

Fu W, Bing Q, JingJing Z, Lijian L, Zhibin X, Qijian D, Jiwen C (2019) Clinicopathological characteristics of renal solitary fibrous tumor: a single institution experience. Medicine (Baltimore) 98:e14618. https://doi.org/10.1097/md.0000000000014618 PubMed DOI

Zaghbib S, Chakroun M, Essid MA, Saadi A, Bouzouita A, Derouiche A, Slama MRB, Ayed H, Chebil M (2019) Solitary fibrous tumor of the kidney: a case report. Int J Surg Case Rep 62:112–114. https://doi.org/10.1016/j.ijscr.2019.08.004 PubMed DOI PMC

De Luca L, Creta M, Barone B, Crocetto F, Cieri M, Campanino MR, Insabato L, Mangiapia F, Fusco F, Imbimbo C, Mirone V, Longo N (2020) A case of incidentally discovered solitary fibrous tumor of the kidney: A case study. Mol Clin Oncol 13:39. https://doi.org/10.3892/mco.2020.2109 PubMed DOI PMC

Marcinek M, Majcherczyk K, Nowak M, Targonski A, Tkocz M (2021) Solitary fibrous tumor of the retroperitoneal space. Case Rep Surg 2021:8857274. https://doi.org/10.1155/2021/8857274 PubMed DOI PMC

Zhang Q, Qin J, Li Y, Wu T (2019) Primary solitary fibrous tumor of kidney: a case report and literature review. Urol Case Rep 23:92–94. https://doi.org/10.1016/j.eucr.2019.01.012 PubMed DOI PMC

Sammoud S, Ferjani S, Hamdani M, Toumi A (2019) Malignant renal solitary fibrous tumor with two local recurrences and distant pulmonary metastasis. Urology 127:9–12. https://doi.org/10.1016/j.urology.2019.01.029 PubMed DOI

Daly A, Dorman AM, Hinchion J (2019) Metastatic solitary fibrous tumour of the kidney presenting more than a decade later with pulmonary disease. Ir Med J 112:954 PubMed

Usuba W, Sasaki H, Yoshie H, Kitajima K, Kudo H, Nakazawa R, Sato Y, Takagi M, Chikaraishi T (2016) Solitary fibrous tumor of the kidney developing local recurrence. Case Rep Urol 2016:2426874. https://doi.org/10.1155/2016/2426874 PubMed DOI PMC

Bezerra ES, Andrighetto OP, Costa MVS, Chiarelli LO, Moleiro W, Schultz L (2018) Bilateral renal involvement by solitary fibrous tumor - report of a case in the post-WHO/2016 era. Urol Case Rep 17:7–9. https://doi.org/10.1016/j.eucr.2017.12.003 PubMed DOI

Zhao G, Li G, Han R (2012) Two malignant solitary fibrous tumors in one kidney: case report and review of the literature. Oncol Lett 4:993–995. https://doi.org/10.3892/ol.2012.858 PubMed DOI PMC

Hertz AM, Childers CK, Wingate JT, Perry JT, Kitley CA, Brand TC, Anderson MI (2019) Malignant solitary fibrous tumor of the renal vein presenting as a giant renal artery aneurysm: a case report and review of literature. Int J Surg Pathol 27:72–76. https://doi.org/10.1177/1066896918787650 PubMed DOI

Almohammad F, Bakour MM (2021) Solitary fibrous renal tumor with thrombus extension into the inferior vena cava and right atrium. Asian Cardiovasc Thorac Ann. https://doi.org/10.1177/0218492321997391 PubMed DOI

Mearini E, Cochetti G, Barillaro F, Fatigoni S, Roila F (2014) Renal malignant solitary fibrous tumor with single lymph node involvement: report of unusual metastasis and review of the literature. Onco Targets Ther 7:679–685. https://doi.org/10.2147/ott.S51664 PubMed DOI PMC

Khowaja A, Johnson-Rabbett B, Bantle J, Moheet A (2014) Hypoglycemia mediated by paraneoplastic production of insulin like growth factor-2 from a malignant renal solitary fibrous tumor - clinical case and literature review. BMC Endocr Disord 14:49. https://doi.org/10.1186/1472-6823-14-49 PubMed DOI PMC

Ma J, Du J, Zhang Z, Wang H, Wang J (2014) Synchronous primary triple carcinoma of thyroid and kidney accompanied by solitary fibrous tumor of the kidney: a unique case report. Int J Clin Exp Pathol 7:4268–4273 PubMed PMC

Ichiyanagi O, Ito H, Takai S, Naito S, Kato T, Nagaoka A, Yamakawa M (2015) A GRIA2 and PAX8-positive renal solitary fibrous tumor with NAB2-STAT6 gene fusion. Diagn Pathol 10:155. https://doi.org/10.1186/s13000-015-0386-x PubMed DOI PMC

Bellizzi AM (2020) An algorithmic immunohistochemical approach to define tumor type and assign site of origin. Adv Anat Pathol 27:114–163. https://doi.org/10.1097/PAP.0000000000000256 PubMed DOI PMC

Argani P, Kao YC, Zhang L, Sung YS, Alaggio R, Swanson D, Matoso A, Dickson BC, Antonescu CR (2019) Bcor overexpression in renal malignant solitary fibrous tumors: a close mimic of clear cell sarcoma of kidney. Am J Surg Pathol 43:773–782. https://doi.org/10.1097/pas.0000000000001243 PubMed DOI PMC

Conzo G, Tartaglia E, Gambardella C, Mauriello C, Esposito D, Mascolo M, Russo D, Stornaiuolo G, Gaeta GB, Santini L (2014) Suprarenal solitary fibrous tumor associated with a NF1 gene mutation mimicking a kidney neoplasm: implications for surgical management. World J Surg Oncol 12:87. https://doi.org/10.1186/1477-7819-12-87 PubMed DOI PMC

Demicco EG, Wagner MJ, Maki RG, Gupta V, Iofin I, Lazar AJ, Wang WL (2017) Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model. Mod Pathol 30:1433–1442. https://doi.org/10.1038/modpathol.2017.54 PubMed DOI

Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, Lazar AJ, Wang WL (2012) Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol 25:1298–1306. https://doi.org/10.1038/modpathol.2012.83 PubMed DOI

McDaniel AS, Palanisamy N, Smith SC, Robinson DR, Wu YM, Chinnaiyan AM, McHugh JB, Greenson JK, Kunju LP (2016) A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall. Histol Histopathol 31:223–230. https://doi.org/10.14670/hh-11-670

Ullman D, Gordetsky J, Siegal GP, Prieto-Granada CN, Wei S, Stevens TM (2019) PAX8 expression in solitary fibrous tumor: a potential diagnostic pitfall. Appl Immunohistochem Mol Morphol 27:195–202. https://doi.org/10.1097/pai.0000000000000561 PubMed DOI

Michalova K, Martinek P, Mezencev R, Gupta S, Williamson S, Wasco M, Mohanty S, Magi-Galluzzi C, Canete-Portillo S, Aron M, Kandukuri S, Lobo J, Barkan GA, Kilic I, Strakova-Peterikova A, Pivovarcikova K, Michal M, Michal M, Ulbright TM, Acosta AM (2025) Renal juxtaglomerular cell tumors exhibit distinct genomic and epigenomic features and lack recurrent gene fusions: comprehensive molecular analysis of a multi-institutional series. Am J Surg Pathol 49:217–226. https://doi.org/10.1097/PAS.0000000000002344 PubMed DOI

Gupta S, Folpe AL, Torres-Mora J, Reuter VE, Zuckerman JE, Falk N, Stanton ML, Muthusamy S, Smith SC, Sharma V, Sethi S, Herrera-Hernandez L, Jimenez RE, Cheville JC (2022) Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors. Hum Pathol 128:110–123. https://doi.org/10.1016/j.humpath.2022.07.016 PubMed DOI

Yamaguchi T, Takimoto T, Yamashita T, Kitahara S, Omura M, Ueda Y (2005) Fat-containing variant of solitary fibrous tumor (lipomatous hemangiopericytoma) arising on surface of kidney. Urology 65:175. https://doi.org/10.1016/j.urology.2004.08.011 PubMed DOI

Cortes LG, Caserta NM, Billis A (2014) Fat-forming solitary fibrous tumor of the kidney: a case report. Anal Quant Cytopathol Histopathol 36:295–298

Bacalbasa N, Balescu I, Jinescu G, Marcu M, Contolenco A, Pop D, Dobritoiu D, Ionescu O, Ionescu P, Stoica C (2018) Fat-forming solitary fibrous tumor of the kidney - a case report and literature review. In Vivo 32:649–652. https://doi.org/10.21873/invivo.11288 PubMed DOI PMC

Doyle LA, Tao D, Mariño-Enríquez A (2014) STAT6 is amplified in a subset of dedifferentiated liposarcoma. Mod Pathol 27:1231–1237. https://doi.org/10.1038/modpathol.2013.247 PubMed DOI

Demicco EG, Harms PW, Patel RM, Smith SC, Ingram D, Torres K, Carskadon SL, Camelo-Piragua S, McHugh JB, Siddiqui J, Palanisamy N, Lucas DR, Lazar AJ, Wang WL (2015) Extensive survey of STAT6 expression in a large series of mesenchymal tumors. Am J Clin Pathol 143:672–682. https://doi.org/10.1309/AJCPN25NJTOUNPNF PubMed DOI

Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL (2014) Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol 27:390–395. https://doi.org/10.1038/modpathol.2013.164 PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...